BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 10728777)

  • 21. Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells.
    Nakajima M; Iwanari M; Yokoi T
    Toxicol Lett; 2003 Sep; 144(2):247-56. PubMed ID: 12927368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction.
    Drahushuk AT; McGarrigle BP; Tai HL; Kitareewan S; Goldstein JA; Olson JR
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):393-403. PubMed ID: 8887457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polybrominated diphenyl ethers as Ah receptor agonists and antagonists.
    Chen G; Bunce NJ
    Toxicol Sci; 2003 Dec; 76(2):310-20. PubMed ID: 14514964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquired resistance to Ah receptor agonists in a population of Atlantic killifish (Fundulus heteroclitus) inhabiting a marine superfund site: in vivo and in vitro studies on the inducibility of xenobiotic metabolizing enzymes.
    Bello SM; Franks DG; Stegeman JJ; Hahn ME
    Toxicol Sci; 2001 Mar; 60(1):77-91. PubMed ID: 11222875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytochrome P4501A induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and two chlorinated dibenzofurans in primary hepatocyte cultures of three avian species.
    Hervé JC; Crump D; Jones SP; Mundy LJ; Giesy JP; Zwiernik MJ; Bursian SJ; Jones PD; Wiseman SB; Wan Y; Kennedy SW
    Toxicol Sci; 2010 Feb; 113(2):380-91. PubMed ID: 19884122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced CYP1A1 gene expression profile in lymphocytes from mice, rats, and humans: most potent induction in humans.
    Nohara K; Ao K; Miyamoto Y; Ito T; Suzuki T; Toyoshiba H; Tohyama C
    Toxicology; 2006 Aug; 225(2-3):204-13. PubMed ID: 16839655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2,3,4,7,8-pentachlorodibenzofuran is a more potent cytochrome P4501A inducer than 2,3,7,8-tetrachlorodibenzo-p-dioxin in herring gull hepatocyte cultures.
    Hervé JC; Crump DL; McLaren KK; Giesy JP; Zwiernik MJ; Bursian SJ; Kennedy SW
    Environ Toxicol Chem; 2010 Sep; 29(9):2088-95. PubMed ID: 20821667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonism of TCDD-induced ethoxyresorufin-O-deethylation activity by polybrominated diphenyl ethers (PBDEs) in primary cynomolgus monkey (Macaca fascicularis) hepatocytes.
    Peters AK; Sanderson JT; Bergman A; van den Berg M
    Toxicol Lett; 2006 Jul; 164(2):123-32. PubMed ID: 16448790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2,3,7,8-Tetrachlorodibenzo-p-dioxin as growth modulator in mouse hepatocytes with high and low affinity Ah receptor.
    Schrenk D; Schäfer S; Bock KW
    Carcinogenesis; 1994 Jan; 15(1):27-31. PubMed ID: 8293544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uroporphyrin accumulation associated with cytochrome P4501A induction in fish hepatoma cells exposed to aryl hydrocarbon receptor agonists, including 2,3,7,8-tetrachlorodibenzo-p-dioxin and planar chlorobiphenyls.
    Hahn ME; Chandran K
    Arch Biochem Biophys; 1996 May; 329(2):163-74. PubMed ID: 8638948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of action of aryl hydrocarbon receptor antagonists: inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression.
    Merchant M; Morrison V; Santostefano M; Safe S
    Arch Biochem Biophys; 1992 Nov; 298(2):389-94. PubMed ID: 1329656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of TCDD on mRNA expression of genes encoding bHLH/PAS proteins in rat hypothalamus.
    Korkalainen M; Lindén J; Tuomisto J; Pohjanvirta R
    Toxicology; 2005 Mar; 208(1):1-11. PubMed ID: 15664428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological modeling of a proposed mechanism of enzyme induction by TCDD.
    Kohn MC; Walker NJ; Kim AH; Portier CJ
    Toxicology; 2001 May; 162(3):193-208. PubMed ID: 11369115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between CYP1A enzyme activities and protein levels in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    DeVito MJ; Beebe LE; Menache M; Birnbaum LS
    J Toxicol Environ Health; 1996 Mar; 47(4):379-94. PubMed ID: 8600290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protopine and allocryptopine increase mRNA levels of cytochromes P450 1A in human hepatocytes and HepG2 cells independently of AhR.
    Vrba J; Vrublova E; Modriansky M; Ulrichova J
    Toxicol Lett; 2011 Jun; 203(2):135-41. PubMed ID: 21419197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor promoters as inhibitors of apoptosis in rat hepatocytes.
    Schrenk D; Schmitz HJ; Bohnenberger S; Wagner B; Wörner W
    Toxicol Lett; 2004 Apr; 149(1-3):43-50. PubMed ID: 15093247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In utero and lactational exposure of the male rat to 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs prostate development. 1. Effects on gene expression.
    Roman BL; Peterson RE
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):240-53. PubMed ID: 9653055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of CYP1A by benzo[k]fluoranthene in human hepatocytes: CYP1A1 or CYP1A2?
    Liu N; Zhang QY; Vakharia D; Dunbar D; Kaminsky LS
    Arch Biochem Biophys; 2001 May; 389(1):130-4. PubMed ID: 11370663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JNK inhibitor SP600125 is a partial agonist of human aryl hydrocarbon receptor and induces CYP1A1 and CYP1A2 genes in primary human hepatocytes.
    Dvorak Z; Vrzal R; Henklova P; Jancova P; Anzenbacherova E; Maurel P; Svecova L; Pavek P; Ehrmann J; Havlik R; Bednar P; Lemr K; Ulrichova J
    Biochem Pharmacol; 2008 Jan; 75(2):580-8. PubMed ID: 17959153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.